These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7654828)

  • 1. Biology and treatment of nasopharyngeal cancer.
    Fandi A; Cvitkovic E
    Curr Opin Oncol; 1995 May; 7(3):255-63. PubMed ID: 7654828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects.
    Altun M; Fandi A; Dupuis O; Cvitkovic E; Krajina Z; Eschwege F
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):859-77. PubMed ID: 7790274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal carcinoma.
    Brennan B
    Orphanet J Rare Dis; 2006 Jun; 1():23. PubMed ID: 16800883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasopharyngeal carcinoma: diagnosis, staging, and management.
    Neel HB
    Oncology (Williston Park); 1992 Feb; 6(2):87-95; discussion 99-102. PubMed ID: 1532503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood nasopharyngeal carcinoma: from biology to treatment.
    Ayan I; Kaytan E; Ayan N
    Lancet Oncol; 2003 Jan; 4(1):13-21. PubMed ID: 12517535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma.
    Wei WI; Sham JS
    Lancet; 2005 Jun 11-17; 365(9476):2041-54. PubMed ID: 15950718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal management of nasopharyngeal carcinoma.
    Faivre S; Janot F; Armand JP
    Curr Opin Oncol; 2004 May; 16(3):231-5. PubMed ID: 15069318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancers of the cavum].
    Marandas P; Marandas N
    Rev Prat; 2000 Sep; 50(14):1556-61. PubMed ID: 11068620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in nasopharyngeal carcinoma.
    Guigay J
    Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undifferentiated carcinoma of nasopharyngeal type (UCNT): a Swiss single-institutional experience during 1990-2005.
    Sidler D; Thum P; Winterhalder R; Huber G; Haerle SK
    Swiss Med Wkly; 2010 May; 140(19-20):273-9. PubMed ID: 19950040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's new in the biology and treatment of undifferentiated carcinoma of nasopharyngeal type?
    Carbone A; Dolcetti R; Shaha AR; Gloghini A; Molinari R; Rinaldo A; Boiocchi M; Wei WI; Ferlito A
    Acta Otolaryngol; 2001 Dec; 121(8):884-95. PubMed ID: 11813890
    [No Abstract]   [Full Text] [Related]  

  • 12. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications.
    Cvitkovic E; Bachouchi M; Armand JP
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):821-38. PubMed ID: 1890068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of nasopharyngeal tumors.
    Oenbrink JD
    South Med J; 1973 Feb; 66(2):209-12. PubMed ID: 4687592
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of nasopharyngeal carcinoma.
    Jeyakumar A; Brickman TM; Jeyakumar A; Doerr T
    Ear Nose Throat J; 2006 Mar; 85(3):168-70, 172-3, 184. PubMed ID: 16615599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Undifferentiated carcinoma of the nasopharynx: epidemiological, clinical and therapeutic aspects].
    Fandi A; Yanes B; Taamma A; Azli N; Armand JP; Dupuis O; Eschwège F; Schwaab G; Cvitkovic E
    Bull Cancer; 1994 Jul; 81(7):571-86. PubMed ID: 7742599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasopharyngeal carcinoma in children--a retrospective review and demonstration of Epstein-Barr viral genomes in tumor cell cytoplasm: a report of the Pediatric Oncology Group.
    Hawkins EP; Krischer JP; Smith BE; Hawkins HK; Finegold MJ
    Hum Pathol; 1990 Aug; 21(8):805-10. PubMed ID: 2167287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.
    Chan AT; Ma BB; Lo YM; Leung SF; Kwan WH; Hui EP; Mok TS; Kam M; Chan LS; Chiu SK; Yu KH; Cheung KY; Lai K; Lai M; Mo F; Yeo W; King A; Johnson PJ; Teo PM; Zee B
    J Clin Oncol; 2004 Aug; 22(15):3053-60. PubMed ID: 15284255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
    Furukawa M; Takimoto T; Morishita K; Komori T; Ishiguro H; Umeda R
    Auris Nasus Larynx; 1983; 10(1):43-8. PubMed ID: 6311149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography.
    Garden AS; Lippman SM; Morrison WH; Glisson BS; Ang KK; Geara F; Hong WK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1005-12. PubMed ID: 8985020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.